InvestorsHub Logo
Followers 40
Posts 6068
Boards Moderated 1
Alias Born 06/29/2011

Re: nferna post# 10655

Tuesday, 05/19/2020 5:10:45 PM

Tuesday, May 19, 2020 5:10:45 PM

Post# of 17447
Those drugs that you mentioned had a lot of issues when they were approved. Voclosporin has no safety issues unlike those drugs. It passed p3 trials with flying colors and is years ahead of its competitors especially with the delay of testing due to the pandemic. Aurinia is one of the most derisked biotech around with a cash to take them To the end of 2021. The small decline in the share value May be atttributed to this pandemic. I am all in n his stock. I hope you will not be foolish enough to dump your shares for a chump change of a gain.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News